Literature DB >> 10368683

Falsification of tetrazolium dye (MTT) based cytotoxicity assay results due to mycoplasma contamination of cell cultures.

J Denecke1, K Becker, H Jürgens, R Gross, J E Wolff.   

Abstract

Mycoplasma contamination of cell cultures is a frequently observed problem. Due to the inconspicuous growth in cell cultures, periodical screening procedures represent the only protection. Many influences of mycoplasma on cell culture parameters have been described. We addressed the question of whether mycoplasma contamination affects the most frequently used cytotoxicity assay, the tetrazolium based MTT assay. We contaminated C6 glioma cells with mycoplasma and performed MTT assays with doxorubicin, vincristine, etoposide and cisplatinum under various conditions. Contaminated cells demonstrated significant different results when tested with the MTT assay than mycoplasma free controls. Differences were not detectable when cells were counted as toxicity assay. Due to an additional reduction of tetrazolium by mycoplasmas, contaminated cells appeared up to 15 fold resistant to doxorubicin, vincristine and etoposide, but not to cisplatinum. Differences decreased with decreasing drug doses and decreasing plated cell count. Our findings confirm the compelling need for periodical mycoplasma screening, especially when tetrazolium based cytotoxicity assay (MTT) are used.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10368683

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Mycoplasma contamination affects cell characteristics and decreases the sensitivity of BV2 microglia to LPS stimulation.

Authors:  Nianhua Feng; Xiaoxi Huang; Yanjun Jia
Journal:  Cytotechnology       Date:  2019-04-03       Impact factor: 2.058

2.  Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies.

Authors:  Karineh Petrossian; Lisa R Banner; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2007-08-16       Impact factor: 2.479

3.  In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.

Authors:  Raymond P Smith; Aldona L Baltch; William J Ritz; Andrea N Carpenter; Tanya A Halse; Lawrence H Bopp
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

4.  Metabolomics reveals mycoplasma contamination interferes with the metabolism of PANC-1 cells.

Authors:  Tao Yu; Yongtao Wang; Huizhen Zhang; Caroline H Johnson; Yiming Jiang; Xiangjun Li; Zeming Wu; Tian Liu; Kristopher W Krausz; Aiming Yu; Frank J Gonzalez; Min Huang; Huichang Bi
Journal:  Anal Bioanal Chem       Date:  2016-04-13       Impact factor: 4.142

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.